C4 Therapeutics Inc CCCC Stock Price Quote

Stock price quote for C4 Therapeutics Inc, symbol CCCC, Nasdaq Stock Exchange.

Quote data is updated continously during trading hours.

C4 Therapeutics Inc Symbol: CCCC Exchange: NSDQ

Most Recent Activity

Activity Today

Yearly Statistics

All market data is delayed by 15 minutes.

Stock price quotations are updated continuously. Click reload to refresh this display.

[Daily], [Weekly] and [Monthly] stock price charts are available for C4 Therapeutics Inc

Most Recent Headlines

MNA: Dec 8th, 2024, 23:47Length: 16773
C4 Therapeutics Presents Cemsidomide Phase 1 Data At The American Society For Hematology (ASH) Annual Meeting That Demonstrated Potential To Become Best-In-Class IKZF1/3 Degrader
MNA: Dec 8th, 2024, 22:50Length: 16773
C4 Therapeutics Presents Cemsidomide Phase 1 Data At The American Society For Hematology (ASH) Annual Meeting That Demonstrated Potential To Become Best-In-Class IKZF1/3 Degrader
MNA: Dec 8th, 2024, 21:55Length: 16773
C4 Therapeutics Presents Cemsidomide Phase 1 Data At The American Society For Hematology (ASH) Annual Meeting That Demonstrated Potential To Become Best-In-Class IKZF1/3 Degrader
MNA: Dec 8th, 2024, 21:00Length: 16773
C4 Therapeutics Presents Cemsidomide Phase 1 Data At The American Society For Hematology (ASH) Annual Meeting That Demonstrated Potential To Become Best-In-Class IKZF1/3 Degrader
MNA: Dec 8th, 2024, 20:05Length: 16773
C4 Therapeutics Presents Cemsidomide Phase 1 Data At The American Society For Hematology (ASH) Annual Meeting That Demonstrated Potential To Become Best-In-Class IKZF1/3 Degrader
MNA: Dec 8th, 2024, 19:09Length: 16773
C4 Therapeutics Presents Cemsidomide Phase 1 Data At The American Society For Hematology (ASH) Annual Meeting That Demonstrated Potential To Become Best-In-Class IKZF1/3 Degrader
MNA: Dec 8th, 2024, 18:14Length: 16773
C4 Therapeutics Presents Cemsidomide Phase 1 Data At The American Society For Hematology (ASH) Annual Meeting That Demonstrated Potential To Become Best-In-Class IKZF1/3 Degrader
MNA: Dec 8th, 2024, 17:16Length: 16773
C4 Therapeutics Presents Cemsidomide Phase 1 Data At The American Society For Hematology (ASH) Annual Meeting That Demonstrated Potential To Become Best-In-Class IKZF1/3 Degrader
MNA: Dec 8th, 2024, 16:20Length: 16773
C4 Therapeutics Presents Cemsidomide Phase 1 Data At The American Society For Hematology (ASH) Annual Meeting That Demonstrated Potential To Become Best-In-Class IKZF1/3 Degrader
MNA: Dec 8th, 2024, 15:26Length: 16773
C4 Therapeutics Presents Cemsidomide Phase 1 Data At The American Society For Hematology (ASH) Annual Meeting That Demonstrated Potential To Become Best-In-Class IKZF1/3 Degrader

Market data delivered to TradingCharts.com, Inc. by Barchart.com.
Although it is believed that information provided is accurate, no guarantee is made.

Stocks TradingCharts.com

Free Stock Prices, Charts & Stock Price Quotes

C4 Therapeutics Inc CCCC Stock Price Quote

Most Recent Headlines